What drove the ALRPD.PA stock jump today?

The pre-market jump was driven by heavy trading relative to average volume (57,453 vs 17,508), screening-driven attention and short-term momentum. No major company press release was in the recent feed; further news would be needed to sustain gains.

Is ALRPD.PA stock a buy after the 50.77% move?

Given negative EPS (-22.77), a tiny market cap (€5.59m) and volatile trading, Meyka AI’s grade (62.21, B, HOLD) suggests cautious positioning. Consider smaller sizes and wait for improving fundamentals before long-term buying.

What price targets and forecasts exist for ALRPD.PA stock?

Meyka AI's forecast model projects a monthly **€7.20** and quarterly **€0.72**. Practical targets we discuss: conservative €6.00, base €11.00, bullish €18.00. Forecasts are model-based and not guarantees.

How risky is trading ALRPD.PA stock on EURONEXT?

Risk is high due to small market cap, negative profitability, and low float that amplifies moves. Use tight risk controls, small position sizes and stop-loss orders when trading ALRPD.PA on EURONEXT.

EU Stocks

ALRPD.PA Rapid Nutrition up 50.77% pre-market EURONEXT 09 Feb 2026: volume surge

ByDanny Kontos February 9, 2026February 9, 2026

ALRPD.PA stock is trading at €11.76 pre-market on EURONEXT after a +50.77% one-day move, driven by a volume surge to 57,453 shares versus an average 17,508. The spike pushed the intraday range to €7.51–€12.56, far above the 50-day average €4.03 and 200-day average €5.13. We assess what the jump means for valuation, technical momentum and near-term forecasts while noting the company’s weak earnings history and small market cap in Europe’s healthcare segment.